Cases 61 - 70 of 915
Otsuka Pharmaceutical Co., Ltd. et al v. Mylan Laboratories Limited et al
as 1:2022cv01125
Plaintiff:
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Defendant:
Mylan Laboratories Limited, Viatris Inc. and Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
CASTILLO v. MYLAN LABORATORIES LTD. et al
as 1:2022cv05097
Plaintiff:
Jose Castillo
Defendant:
MYLAN LABORATORIES LTD., MYLAN N.V., MYLAN PHAMACEUTICALS INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
RODRIGUEZ et al v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv05040
Plaintiff:
ESTEBAN C RODRIGUEZ, ESTEBAN C. RODRIGUEZ and DIANA R. BALAY
Defendant:
AUROBINDO PHARMA LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc.
as 1:2022cv01040
Counter Defendant:
Novo Nordisk Inc.
Plaintiff:
Novo Nordisk A/S
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In Re: Ozempic (Semaglutide) Patent Litigation
as 1:2022md03038
Not Classified By Court:
Zydus Lifesciences Limited, Ozempic (Semaglutide) Patent Litigation, Novo Nordisk Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
CARTER v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv04800
Plaintiff:
TIERRA CARTER
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES, LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Langford v. Mylan Pharmaceuticals, Inc.
as 1:2022cv04691
Plaintiff:
Maranda Langford
Defendant:
MYLAN PHARMACEUTICALS INC.
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
BACQUE v. MYLAN LABORATORIES LTD. et al
as 1:2022cv04572
Plaintiff:
KENNETH BACQUE
Defendant:
MYLAN LABORATORIES LTD., MYLAN, N.V., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
CLARK v. MYLAN LABORATORIES LTD. et al
as 1:2022cv04533
Plaintiff:
RITA CHIKHI and RICHARD CLARK
Defendant:
MYLAN LABORATORIES LTD., JOHN DOE, MYLAN PHARMACEUTICALS INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
In re: Somaxon Pharmaceuticals Inc
as 1:2022mc00275
Respondent:
Somaxon Pharmaceuticals Inc., Currax Pharmaceuticals LLC, Currax Holdings LLC and others
Petitioner:
Mylan Inc. and Mylan Pharmaceuticals Inc.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
